![Atreca, Inc.](https://s33007.pcdn.co/wp-content/uploads/2020/02/Atreca-Inc.jpg)
Atreca is a biopharmaceutical company utilizing its differentiated platform to discover and develop novel antibody-based immunotherapeutics to treat a range of solid tumor types. Atreca’s approach to drug development relies on the human immune system to direct it to unique antibody-target pairs from patients experiencing a clinically meaningful, active immune response against their tumors.